Financial comparisons Bolt Biotherapeutics, Inc.
Equities
BOLT
US0977022039
Biotechnology & Medical Research
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 6.320 USD | +1.61% |
|
+6.76% | -40.95% |
| 06-06 | Bolt Biotherapeutics Announces 120 Reverse Stock Split Effective June 6, 2025 | RE |
| 05-12 | Bolt Biotherapeutics, Inc. - Special Call |
Main competitors
| Revenues (Y-1) | Net Margin (Y-1) | EBIT Margin (Y-1) | ROE (Y-1) | ROA (Y-1) | Leverage (Y-1) | ||
|---|---|---|---|---|---|---|---|
| 7.69M | -820.78% | -949.91% | - | - | - | ||
| 2.22B | 36.99% | -0.96% | 2.26% | 2.02% | 234.49x | ||
| 2.85B | -24.18% | -47.77% | -3.3% | -2.88% | 9.36x | ||
| 5.38B | 24.08% | 29.51% | 16.78% | 12.27% | -0.97x | ||
| 364M | -251.24% | -241.47% | -1,601.19% | -54.47% | 0.16x | ||
| 2.99B | 36.44% | 32.53% | 22.97% | 19.34% | -2.97x | ||
| 2.56B | 17.97% | 25.37% | 11.65% | 8.43% | -0.66x | ||
| 291M | -24.22% | -26.28% | -8.94% | -4.69% | -2.82x | ||
| 2.17B | 24.04% | 27.88% | 23.13% | 17.7% | -1.75x | ||
| 265M | -13.8% | -7.18% | -9.46% | -9.11% | 3.86x | ||
| 41.93M | -410.18% | -365.73% | - | - | - | ||
| 627M | -28.22% | -21.76% | -15.45% | -10.06% | 13.02x | ||
| 180M | -258.64% | -276.39% | -80.35% | - | 1.63x | ||
| 297M | 30.46% | 17.83% | 7.52% | 6.63% | -9.98x | ||
| 487M | 40.03% | 45.91% | 30.74% | 24.08% | - | ||
| 1.79B | 6.64% | 9.69% | 4.89% | 1.76% | 4.17x | ||
| 235M | -85.53% | -78.53% | -54.06% | -26.62% | -1.54x | ||
| Average | 1.34B | -100.01% | -107.49% | -110.19% | -1.11% | 17.57x | |
| Weighted average by Cap. | 2.05B | -39.84% | -45.18% | -140.26% | -1.17% | 41.58x |
- Stock Market
- Equities
- BOLT Stock
- Sector Bolt Biotherapeutics, Inc.
- Financial comparisons
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition